Q1 2025 Alcon AG Earnings Call Transcript
Key Points
- Alcon Inc (ALC) reported sales of $2.5 billion for the first quarter, reflecting a 3% growth, showcasing the company's resilience despite a soft US surgical market.
- The launch of Unity VCS and PanOptix Pro is expected to drive significant growth in the latter half of the year, with high single-digit revenue growth anticipated.
- Alcon Inc (ALC) acquired a majority interest in Aurion Biotech, which could revolutionize corneal transplantation and potentially generate peak sales of $0.5 billion or more.
- The company's Vision Care segment saw strong growth, particularly in innovative lenses like Precision 1 and Total 30 families, which grew double digits.
- Alcon Inc (ALC) is actively mitigating tariff impacts through strategic measures such as supplier diversification and optimizing its manufacturing network, aiming to offset the $80 million tariff pressure.
- The US surgical market remains soft, impacting Alcon Inc (ALC)'s implantable sales, which were flat year-over-year at $420 million.
- Alcon Inc (ALC) faces competitive pressures in the US market, particularly in the advanced technology IOLs segment.
- The company's equipment sales declined by 6% year-over-year, although growth is expected to accelerate in the second half of the year.
- Tariff impacts are expected to pressure cost of sales by approximately $80 million for the full year, with most of the impact in the second half.
- Alcon Inc (ALC) has updated its full-year revenue guidance to reflect a softer US surgical market, now expecting sales growth of 6% to 7% in constant currency.
Greetings, and welcome to the Alcon first quarter 2025 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Dan Cravens, VP of Investor Relations. Thank you. You may begin.
Welcome to Alcon's first quarter 2025 earnings conference call. Yesterday, we issued a press release, interim financial report and presentation. You can find all these documents on our website at investor.alcon.com.
Please note that starting this quarter in order to streamline our reporting the interim financial report and other filings will be limited to information required by regulations. Non-IFRS results, including constant currency growth and core items will only be presented in the press release and presentation.
Joining me on today's call are David Endicott, our Chief Executive Officer; and Tim Stonesifer, our Chief Financial Officer.
Our press release, presentation and discussion will include forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
